CLINIQUE BELLEVUE AS

4010 STAVANGER

Finances

Share Ownership

Return on Equity

0,92 %

Current Ratio

0,11

Debt-to-Equity Ratio

−0

Key figures (NOK)	2022	2021	2020	2019
Revenue	8 028 000	7 876 000	9 602 000	8 641 000
Net Income	−42 000	−646 000	581 000	555 000
Total Assets	1 856 000	1 917 000	2 035 000	1 235 000
Total Equity	−4 556 000	−4 514 000	−3 867 000	−4 448 000

Income (NOK)	2022	2021	2020	2019
Revenue	8 028 000	7 876 000	9 602 000	8 641 000
Expenditure	8 066 000	8 524 000	9 021 000	8 068 000
Operating Profit	−38 000	−647 000	581 000	572 000
Financial Income	0	1 000	0	0
Financial Costs	4 000	0	1 000	17 000
Financial Balance	−4 000	1 000	−1 000	−17 000
Earnings Before Tax	−42 000	−646 000	581 000	555 000
Tax	0	0	0	0
Net Income	−42 000	−646 000	581 000	555 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 134 000	1 048 000	690 000	802 000
Total Current Assets	722 000	869 000	1 344 000	433 000
Total Assets	1 856 000	1 917 000	2 035 000	1 235 000
Total Retained Equity	−4 586 000	−4 544 000	−3 897 000	−4 478 000
Total Equity	−4 556 000	−4 514 000	−3 867 000	−4 448 000
Total Long-Term Debt	0	0	51 000	0
Total Current Debt	6 411 000	6 431 000	5 852 000	5 683 000
Total Equity and Debt	1 856 000	1 917 000	2 035 000	1 235 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	8 028 000	7 876 000	8 638 000	8 319 000
Other Income	0	0	964 000	322 000
Revenue	8 028 000	7 876 000	9 602 000	8 641 000
Cost of Goods Sold	4 288 000	4 820 000	4 939 000	3 425 000
Salary Costs	948 000	639 000	986 000	1 249 000
Depreciation	210 000	144 000	112 000	106 000
Impairment	0	0	0	0
Expenditure	8 066 000	8 524 000	9 021 000	8 068 000
Operating Profit	−38 000	−647 000	581 000	572 000
Financial Income	0	1 000	0	0
Financial Costs	4 000	0	1 000	17 000
Financial Balance	−4 000	1 000	−1 000	−17 000
Dividends	0	0	0	0
Net Income	−42 000	−646 000	581 000	555 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 134 000	1 048 000	690 000	802 000
Total Tangible Assets	1 134 000	1 048 000	690 000	802 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 134 000	1 048 000	690 000	802 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	445 000	292 000	1 158 000	393 000
Total Current Assets	722 000	869 000	1 344 000	433 000
Total Assets	1 856 000	1 917 000	2 035 000	1 235 000
Total Equity	−4 556 000	−4 514 000	−3 867 000	−4 448 000
Short-Term Group Debt	2 016 000	2 016 000	616 000	2 694 000
Total Long-Term Debt	0	0	51 000	0
Creditors	3 321 000	3 182 000	4 104 000	1 526 000
Unpaid Taxes	170 000	211 000	73 000	103 000
Dividends	0	0	0	0
Other Current Debt	905 000	1 022 000	1 059 000	1 360 000
Total Current Debt	6 411 000	6 431 000	5 852 000	5 683 000
Total Equity and Debt	1 856 000	1 917 000	2 035 000	1 235 000

Financial indicators	2022	2021	2020	2019
Return on Equity	0,92 %	14,31 %	−15,02 %	−12,48 %
Debt-to-Equity Ratio	−0	−0	−0,01	−0
Operating Profit Margin	−0,47 %	−8,21 %	6,05 %	6,62 %
Current Ratio	0,11	0,14	0,23	0,08
Quick Ratio	0,11	0,14	0,23	0,08
Equity Ratio	−2,45	−2,35	−1,9	−3,6
Gross Profit Margin	46,59 %	38,8 %	48,56 %	60,36 %